I am a...PatientCaregiverHealthcare ProviderOther
Δ
*
I am a...OphthalmologistIRD SpecialistVitreoretinal surgeonOptometristGeneticistPrimary Care ProviderOther
Does the individual with XLRP currently live in the US?YesNo
Is the individual with XRLP between the age of 8 and 50?YesNoI don’t know
Do you have the medical, genetic test results, or ophthalmology records of the individual with XLRP?YesNoOther
Has the person with XLRP (or one of their family members) received genetic testing to confirm a mutation in the RPGR gene?YesNoI don’t know
How did you learn about the trial (check all that apply): BluePrint GeneticscommunicationFoundation Fighting BlindnessFighting Blindness CanadaClinicaltrials.govInternet ad or social mediaOther
I am a...Person with XLRP who has a confirmed mutation in the RPGR genePerson with RP who has not received genetic testing to confirm my mutationFamily or caregiver of person with XLRPOther
AGTC is now pre-screening for a phase 2/3 clinical trial of an investigational gene therapy in people with X-Linked Retinitis Pigmentosa.
Learn more about the clinical trial or how to qualify for pre-screening:
I am a patient
I am a Healthcare Professional
© agtc. All rights reserved.
